20
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Animal models of PTSD: a challenge to be met

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recent years have seen increased interest in psychopathologies related to trauma exposure. Specifically, there has been a growing awareness to posttraumatic stress disorder (PTSD) in part due to terrorism, climate change-associated natural disasters, the global refugee crisis, and increased violence in overpopulated urban areas. However, notwithstanding the increased awareness to the disorder, the increasing number of patients, and the devastating impact on the lives of patients and their families, the efficacy of available treatments remains limited and highly unsatisfactory. A major scientific effort is therefore devoted to unravel the neural mechanisms underlying PTSD with the aim of paving the way to developing novel or improved treatment approaches and drugs to treat PTSD. One of the major scientific tools used to gain insight into understanding physiological and neuronal mechanisms underlying diseases and for treatment development is the use of animal models of human diseases. While much progress has been made using these models in understanding mechanisms of conditioned fear and fear memory, the gained knowledge has not yet led to better treatment options for PTSD patients. This poor translational outcome has already led some scientists and pharmaceutical companies, who do not in general hold opinions against animal models, to propose that those models should be abandoned. Here, we critically examine aspects of animal models of PTSD that may have contributed to the relative lack of translatability, including the focus on the exposure to trauma, overlooking individual and sex differences, and the contribution of risk factors. Based on findings from recent years, we propose research-based modifications that we believe are required in order to overcome some of the shortcomings of previous practice. These modifications include the usage of animal models of PTSD which incorporate risk factors and of the behavioral profiling analysis of individuals in a sample. These modifications are aimed to address factors such as individual predisposition and resilience, thus taking into consideration the fact that only a fraction of individuals exposed to trauma develop PTSD. We suggest that with an appropriate shift of practice, animal models are not only a valuable tool to enhance our understanding of fear and memory processes, but could serve as effective platforms for understanding PTSD, for PTSD drug development and drug testing.

          Related collections

          Most cited references278

          • Record: found
          • Abstract: found
          • Article: not found

          Animal models of neuropsychiatric disorders.

          Modeling of human neuropsychiatric disorders in animals is extremely challenging given the subjective nature of many symptoms, the lack of biomarkers and objective diagnostic tests, and the early state of the relevant neurobiology and genetics. Nonetheless, progress in understanding pathophysiology and in treatment development would benefit greatly from improved animal models. Here we review the current state of animal models of mental illness, with a focus on schizophrenia, depression and bipolar disorder. We argue for areas of focus that might increase the likelihood of creating more useful models, at least for some disorders, and for explicit guidelines when animal models are reported.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research.

            Meta-analyses of studies yielding sex-specific risk of potentially traumatic events (PTEs) and posttraumatic stress disorder (PTSD) indicated that female participants were more likely than male participants to meet criteria for PTSD, although they were less likely to experience PTEs. Female participants were more likely than male participants to experience sexual assault and child sexual abuse, but less likely to experience accidents, nonsexual assaults, witnessing death or injury, disaster or fire, and combat or war. Among victims of specific PTEs (excluding sexual assault or abuse), female participants exhibited greater PTSD. Thus, sex differences in risk of exposure to particular types of PTE can only partially account for the differential PTSD risk in male and female participants. (c) 2006 APA, All Rights Reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions.

              Although the fact that genetic predisposition and environmental exposures interact to shape development and function of the human brain and, ultimately, the risk of psychiatric disorders has drawn wide interest, the corresponding molecular mechanisms have not yet been elucidated. We found that a functional polymorphism altering chromatin interaction between the transcription start site and long-range enhancers in the FK506 binding protein 5 (FKBP5) gene, an important regulator of the stress hormone system, increased the risk of developing stress-related psychiatric disorders in adulthood by allele-specific, childhood trauma-dependent DNA demethylation in functional glucocorticoid response elements of FKBP5. This demethylation was linked to increased stress-dependent gene transcription followed by a long-term dysregulation of the stress hormone system and a global effect on the function of immune cells and brain areas associated with stress regulation. This identification of molecular mechanisms of genotype-directed long-term environmental reactivity will be useful for designing more effective treatment strategies for stress-related disorders.
                Bookmark

                Author and article information

                Contributors
                972-4-8240962 , galrichterlevin@gmail.com
                Journal
                Mol Psychiatry
                Mol. Psychiatry
                Molecular Psychiatry
                Nature Publishing Group UK (London )
                1359-4184
                1476-5578
                19 October 2018
                19 October 2018
                2019
                : 24
                : 8
                : 1135-1156
                Affiliations
                [1 ]ISNI 0000 0004 1937 0562, GRID grid.18098.38, Sagol Department of Neurobiology, , University of Haifa, ; Haifa, Israel
                [2 ]ISNI 0000 0004 1937 0562, GRID grid.18098.38, The Integrated Brain and Behavior Research Center (IBBR), , University of Haifa, ; Haifa, Israel
                [3 ]ISNI 0000 0004 1937 0562, GRID grid.18098.38, Psychology Department, , University of Haifa, ; Haifa, Israel
                [4 ]ISNI 0000 0001 1018 4307, GRID grid.5807.a, Department of Genetics & Molecular Neurobiology, Institute of Biology, , Otto-von-Guericke-University Magdeburg, ; Leipziger Str. 44, 39120 Magdeburg, Germany
                [5 ]GRID grid.452320.2, Center for Behavioral Brain Sciences, ; Universitätsplatz 2, 39106 Magdeburg, Germany
                [6 ]ISNI 0000 0000 9497 5095, GRID grid.419548.5, Department of Stress Neurobiology and Neurogenetics, , Max Planck Institute of Psychiatry, ; Munich, Germany
                Article
                272
                10.1038/s41380-018-0272-5
                6756084
                30816289
                405621f9-d36b-40fa-bf7e-75acb947f9a9
                © The Author(s) 2018

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 23 September 2017
                : 13 August 2018
                : 11 September 2018
                Funding
                Funded by: State of Israel Ministry of Science, Technology, & Space research grant no. 3-13563 to GR-L and DFG grant STO 488/6-1 to OS and GR-L
                Categories
                Expert Review
                Custom metadata
                © Springer Nature Limited 2019

                Molecular medicine
                neuroscience,drug discovery
                Molecular medicine
                neuroscience, drug discovery

                Comments

                Comment on this article